title: Serum B-cell activating factor in myeloperoxiase-antineutrophil cytoplasmic antibodies-associated vasculitis.
abstract: BACKGROUND
  In this study, the serum B-cell activating factor belonging to tumor necrosis factor family (BAFF) levels in patients with myeloperoxidase (MPO)-antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) were measured, and their clinical significance was further analyzed.
  
  
  METHODS
  One hundred twenty-one patients with MPO-AAV were enrolled in this study. Eighty-three patients had active vasculitis and 38 were in remission. Fifty-five healthy individuals were used as healthy controls. The levels of serum BAFF were assessed using commercial available enzyme-linked immunosorbent assay kits. The correlations between serum BAFF and Birmingham Vasculitis Activity Score, erythrocyte sedimentation rate and MPO-ANCA were further evaluated.
  
  
  RESULTS
  The levels of serum BAFF of patients with MPO-AAV in both active (6.06±5.02 ng/mL) and remission phases (3.60±3.83 ng/mL) were significantly higher than those in healthy controls (0.87±0.31 ng/mL) (P<0.001, respectively). The serum BAFF levels in patients with active vasculitis were significantly higher than those in remission (P<0.001). Serum BAFF levels were significantly correlated with Birmingham Vasculitis Activity Score (r=0.320, P<0.001) and erythrocyte sedimentation rate value (r=0.311, P<0.01) in all patients, but no correlation was found between the levels of serum BAFF and MPO-ANCA. Using receiver-operating characteristics statistics, the cutoff values of serum BAFF level for indicating the presence of MPO-AAV and active vasculitis were 1.58 and 4.20 ng/mL, respectively.
  
  
  CONCLUSIONS
  The levels of serum BAFF were elevated in patients with MPO-AAV and associated with disease activity, but they were not related with the levels of MPO-ANCA.
authors.affiliation: Department of Microbiology and Immunology (GX, YS, K-SL), Shantou University Medical College, Shantou, Guangdong, People's Republic of China; Renal Division (MC, M-HZ), Peking University First Hospital, Beijing, People's Republic of China; and Department of Nephrology (L-XX), Guangdong General Hospital, Guangzhou, Guangdong, People's Republic of China.
authors.forename: Gang
authors.initials: G
authors.lastname: Xin
authors.forename: Min
authors.initials: M
authors.lastname: Chen
authors.forename: Yun
authors.initials: Y
authors.lastname: Su
authors.forename: Li-Xia
authors.initials: LX
authors.lastname: Xu
authors.forename: Ming-Hui
authors.initials: MH
authors.lastname: Zhao
authors.forename: Kang-Sheng
authors.initials: KS
authors.lastname: Li
mesh_terms: D000328:Adult; D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D053264:B-Cell Activating Factor / Q000096:biosynthesis / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D003593:Cytoplasm / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000276:immunology / Q000473:pathology; D009195:Peroxidase / Q000097:blood* / Q000276:immunology; D014657:Vasculitis / Q000097:blood* / Q000276:immunology / Q000473:pathology
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D053264:B-Cell Activating Factor; D015415:Biomarkers; D009195:Peroxidase